Aeolus Pharmaceuticals Inc (AOLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 403 | 981 | 1,895 | 3,155 | 3,756 |
| Receivables | 313 | 603 | 544 | 750 | 742 |
| Other current assets | 0 | 0 | 0 | 0 | 26 |
| TOTAL | $762 | $1,733 | $2,617 | $4,135 | $4,841 |
| Non-Current Assets | |||||
| Investments And Advances | 32 | 32 | 32 | 32 | 32 |
| TOTAL | $32 | $32 | $32 | $32 | $32 |
| Total Assets | $794 | $1,765 | $2,649 | $4,167 | $4,873 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 587 | 638 | 514 | 972 | 661 |
| TOTAL | $587 | $638 | $514 | $972 | $688 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | N/A | 27 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $587 | $638 | $514 | $972 | $688 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 152,086 | 152,086 | 152,086 | 152,086 | 152,086 |
| Common Shares | 1,520 | 1,520 | 1,520 | 1,520 | 1,521 |
| Retained earnings | -193,259 | -192,310 | -191,275 | -190,188 | -189,166 |
| TOTAL | $207 | $1,127 | $2,135 | $3,195 | $4,185 |
| Total Liabilities And Equity | $794 | $1,765 | $2,649 | $4,167 | $4,873 |